Detalhe da pesquisa
1.
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant.
Blood
; 137(19): 2585-2597, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33270816
2.
A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia.
Acta Haematol
; 140(1): 30-39, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30071517
3.
An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes.
Am J Hematol
; 92(7): 674-682, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28370157
4.
Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study.
Lancet Haematol
; 11(1): e15-e26, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135371
5.
Use of ifosfamide, carboplatin and etoposide in combination with brentuximab vedotin or romidepsin based on CD30 positivity in relapsed/refractory peripheral T-cell lymphoma.
Cancer Rep (Hoboken)
; 5(7): e1581, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35263030
6.
The development of T-cell malignancies in patients with pre-existing myeloproliferative neoplasms: a report of three cases.
Ecancermedicalscience
; 14: 1011, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32256694
7.
Final outcomes of escalated melphalan 280 mg/m2 with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival.
Bone Marrow Transplant
; 54(2): 293-299, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29907806
8.
Primary CNS Lymphoma Arising from the 4th Ventricle: A Case Report and Review of the Literature.
Case Rep Oncol Med
; 2019: 2671794, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31093392
9.
A review of supportive care and recommended preventive approaches for patients with chronic lymphocytic leukemia.
Expert Rev Hematol
; 9(3): 235-44, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26652692
10.
Splenomegaly in myelofibrosis--new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors.
J Hematol Oncol
; 5: 43, 2012 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22852872
11.
Clinical regression of squamous cell carcinoma and keratoacanthomas in a patient treated with a hypomethylating agent.
Int J Dermatol
; 53(1): e13-4, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22998756